Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximing Zeng

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|March 17, 2017
miR-455 inhibits breast cancer cell proliferation through targeting CDK14Bing Wang, Aimei Zou, Liqiang Ma, et al.
Frontiers in Immunology|March 18, 2025
The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanismHanxuan Yang, Ximing Zeng, Xiaochuan Chen, et al.
Head & Face Medicine|September 28, 2024
Early recurrence as a pivotal event in nasopharyngeal carcinoma: identifying predictors and key molecular signals for survivorsYing Li, Zongwei Huang, Ximing Zeng, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|March 17, 2017
miR-455 inhibits breast cancer cell proliferation through targeting CDK14Bing Wang, Aimei Zou, Liqiang Ma, et al.
Frontiers in Immunology|March 18, 2025
The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanismHanxuan Yang, Ximing Zeng, Xiaochuan Chen, et al.
Head & Face Medicine|September 28, 2024
Early recurrence as a pivotal event in nasopharyngeal carcinoma: identifying predictors and key molecular signals for survivorsYing Li, Zongwei Huang, Ximing Zeng, et al.
Pageof 1